Cargando…
TBI+rATG为基础的联合预处理方案单倍体造血干细胞移植治疗化疗耐药进展期外周T细胞淋巴瘤11例
OBJECTIVE: To evaluate the clinical outcomes and safety of haploidentical hematopoietic stem cell transplantation(haplo-HSCT)using a conditioning regimen based on total body irradiation(TBI)and rabbit anti-human thymocyte globulin(rATG)in the management of chemotherapy-resistant advanced peripheral...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509615/ https://www.ncbi.nlm.nih.gov/pubmed/37749039 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.07.010 |
Ejemplares similares
-
替加环素为基础的联合方案治疗33例泛耐药革兰阴性杆菌感染血液病患者的临床研究
Publicado: (2015) -
一线化疗方案治疗广泛期小细胞肺癌的网状meta分析
Publicado: (2016) -
肺癌干性样细胞与耐药
Publicado: (2022) -
一代与二代酪氨酸激酶抑制剂为基础的方案治疗BCR-ABL阳性急性淋巴细胞白血病疗效比较
Publicado: (2019) -
Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
Publicado: (2011)